Q BioMed Inc. (QBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Q BioMed Company Description
Q BioMed Inc. engages in the acquisition, development, and financing of biomedical assets.
The company offers Strontium Chloride Sr-89/Metastron, a radiopharmaceutical for the treatment of metastatic cancer bone pain.
It also develops various preclinical candidates comprising QBM-001 for rare pediatric non-verbal autism spectrum disorder; UTTROSIDE-B, a chemotherapeutic for liver cancer; and MAN-01, a topical eyedrops for glaucoma.
The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015.
Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.
Contact Details
Address: 366 Madison Avenue New York, New York 10017 United States | |
| Phone | 646 889 2226 |
| Website | qbiomed.com |
Stock Details
| Ticker Symbol | QBIO |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | December - November |
| Reporting Currency | USD |
| ISIN Number | US74736N1054 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Denis D. Corin | Chairman, Chief Executive Officer and President |
| Ari Jatwes | Director of Finance |